Package Leaflet: Information for the User
Neupro 1 mg/24 h Transdermal Patch
Neupro 3 mg/24 h Transdermal Patch
Ropinirole
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack and other information:
What is Neupro
Neupro contains the active substance ropinirole.
It belongs to a group of medicines known as “dopamine agonists”. Dopamine is an important messenger in the brain for movement.
What is Neupro used for
Neupro is used in adults to treat the signs and symptoms of:
Do not use Neupro if:
You must remove the Neupro patch just before having an MRI scan or cardioversion to avoid skin burns because the patch contains aluminum. You can put on a new patch when these tests are over.
Do not use Neupro if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist first.
Warnings and precautions
Talk to your doctor or pharmacist before you start using Neupro, as:
You may lose consciousness
Neupro may cause loss of consciousness. This can happen especially when you start treatment with Neupro or when you increase the dose. Tell your doctor if you lose consciousness or feel dizzy.
Changes in behavior and abnormal thoughts
Neupro may cause side effects that change your behavior (how you act). If your family or caregiver, or your doctor, are concerned about changes in your behavior, it may be helpful to tell a family member or caregiver that you are using this medicine and for them to read this leaflet.
For more information, see ‘Changes in behavior and abnormal thoughts’ in section 4.
Children and adolescents
This medicine must notbe given to childrenunder 18 years because its safety and effectiveness in this age group are not known.
Using Neupro with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. This includes medicines that you buy without a prescription and herbal medicines.
Do not take the following medicines while you are using Neupro, as they may reduce its effect:
Talk to your doctor before using Neupro if you are taking:
Your doctor will tell you if it is safe to take these medicines while you are using Neupro.
Using Neupro with food, drinks, and alcohol
Since ropinirole enters the bloodstream through the skin, taking food or drinks does not affect how this medicine is absorbed. You should talk to your doctor if you can drink alcohol while using Neupro.
Pregnancy and breastfeeding
Do not use Neupro if you are pregnant. This is because the effects of ropinirole on pregnancy and the unborn child are not known.
Do not breastfeed while you are using Neupro. This is because ropinirole may pass into breast milk and affect your baby. It may also reduce the amount of milk produced.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Driving and using machines
Neupro may make you feel very sleepy or fall asleep suddenly. If this happens, do not drive.
In rare cases, some people have fallen asleep while driving when using Neupro.
Do not use tools or machines if you feel very sleepy - or do any other activity that could put you or others at risk of serious harm.
Neupro contains sodium metabisulfite (E223)
Neupro contains sodium metabisulfite (E223), a substance that can rarely cause severe allergic reactions and bronchospasm (difficulty breathing due to narrowing of the airways).
Follow the instructions for using this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
What patch dose to use
Neupro is available in patches of different strengths that release the medicine over 24 hours. The strengths are 1 mg/24 h, 2 mg/24 h, and 3 mg/24 h for the treatment of Restless Legs Syndrome.
If you have to stop using this medicine, see “If you stop using Neupro” in section 3.
How to use the Neupro patches
Neupro is a patch that you apply to your skin.
Where to apply the patch Apply the adhesive side of the patch to clean, dry, and healthy skin on the following areas, as indicated by the grey areas in the diagram:
|
To avoid skin irritation
|
If you continue to have skin problems caused by the patch, see “Skin problems caused by the patch” in section 4 for more information.
To prevent the patch from coming loose or falling off
If the patch falls off, you should apply a new one for the rest of the day and the next day, apply a new patch at the usual time.
How to use the patch
1. To open the pouch, hold both sides of the pouch with both hands. | |
2. Peel off the liners. | |
3. Open the pouch. | |
4. Remove the patch from the pouch. | |
5. The adhesive side of the patch is covered by a transparent disposable liner.
| |
6.
| |
7.
| |
8.
| |
9. Fold back the other half of the patch and remove the rest of the disposable liner. | |
10.
This ensures that the patch is in contact with your skin and the edges are well stuck. | |
11. Wash your hands with soap and water immediately after handling the patch. |
How to remove the used patch
If you use more Neupro than you should
Using higher doses of Neupro than your doctor has prescribed may cause side effects such as nausea or vomiting, low blood pressure, seeing or hearing things that are not real (hallucinations), confusion, extreme sleepiness, involuntary movements, and convulsions.
In these cases, tell your doctor or go to the hospital as soon as possible. They will tell you what to do.
If you forget to change the patch at the usual time
In both cases, the next day, apply a new patch at the usual time. Do not use a double dose to make up for forgotten doses.
If you stop using Neupro
Do not stop using Neupro without talking to your doctor first. Stopping Neupro suddenly may cause you to have a condition called ‘neuroleptic malignant syndrome’ which can be life-threatening. The signs include: loss of muscle movement (akinesia), muscle stiffness, fever, unstable blood pressure, increased heart rate (tachycardia), confusion, decreased consciousness (for example, coma).
If your doctor tells you to stop using Neupro, the daily doseof Neupro should be gradually reduced:
If you have any other questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. Inform your doctor or pharmacist if you notice any adverse effect.
Most Likely Adverse Effects at the Start of Treatment
You may experience nauseaand vomiting at the start of treatment. These effects are usually mild or moderate and last for a short time. You should consult your doctorif the effects last for a long time or if you are concerned.
Skin Problems Caused by the Patch
You May Experience Loss of Consciousness
Neupro can cause loss of consciousness. This can happen especially when starting treatment with Neupro or when increasing the dose. Inform your doctor if you lose consciousness or feel dizzy.
Changes in Behavior and Abnormal Thoughts
Inform your doctor if you notice any change in behavior, thought, or both, as indicated below.
Your doctor will indicate how to manage or reduce the symptoms.
If your family or caregiver, or your doctor, are concerned about changes in your behavior, it may be helpful to tell a family member or caregiver that you are using this medicine and to read the package insert. Neupro can cause anxiety or an overwhelming urge to behave abnormally and be unable to control the impulse, attack, or temptation to perform certain actions that may harm you or others.
These actions may include:
Neupro can cause other abnormal behaviors and thoughts, which may include:
Inform your doctor if you notice any change in your behavior, thought, or both, as indicated above.
Your doctor will indicate how to manage or reduce the symptoms.
Allergic Reactions
Inform your doctor if you notice signs of an allergic reaction – which may include swelling of the face, tongue, or lips.
Adverse Effects if You Use Neupro for Restless Legs Syndrome
Inform your doctor or pharmacist if you experience any of the following adverse effects:
Very Common: may affect more than 1 in 10 patients
Common: may affect up to 1 in 10 patients
Uncommon: may affect up to 1 in 100 patients
Rare: may affect up to 1 in 1,000 patients
Not Known: frequency not known
Inform your doctor or pharmacist if you experience any of these adverse effects.
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this package insert. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date shown on the label and carton.
Do not store above 30°C.
What to Do with Used and Unused Patches
Used patches still contain the active ingredient, 'rotigotine', which can be hazardous to others. Fold the used patch with the adhesive side inward. Place the patch in the original envelope and then throw it away in a safe place, out of the reach of children.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Neupro
The active ingredient is rotigotine.
A patch releases 1 mg of rotigotine every 24 hours. Each 5 cm2 patch contains 2.25 mg of rotigotine.
A patch releases 3 mg of rotigotine every 24 hours. Each 15 cm2 patch contains 6.75 mg of rotigotine.
The other ingredients are:
Appearance and Package Contents
Neupro is a transdermal patch. It is thin and has three layers. It is square in shape with rounded corners. The outer layer is brown in color and bears the inscription Neupro 1 mg/24 h or 3 mg/24 h.
Neupro is available in the following formats:
Cartons containing 7, 14, 28, 30, or 84 (multiple package containing 3 cartons of 28) patches, each patch is included in an individual envelope.
Not all pack sizes may be marketed.
Marketing Authorization Holder
UCB Pharma S.A.
Allée de la Recherche 60
B-1070 Brussels
Belgium
Manufacturer
UCB Pharma S.A.
Chemin du Foriest
B-1420 Braine l’Alleud
Belgium
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien UCB Pharma SA/NV Tel: +32-(0)2 559 92 00 | Lietuva UCB Pharma Oy Finland Tel: +358-92 514 4221 (Suomija) |
Luxembourg/Luxemburg UCB Pharma SA/NV Tél/Tel: +32-(0)2 559 92 00 | |
Ceská republika UCB s.r.o. Tel: +420-221 773 411 | Magyarország UCB Magyarország Kft. Tel.: +36-(1) 391 0060 |
Danmark UCB Nordic A/S Tlf.: +45-32 46 24 00 | Malta Pharmasud Ltd. Tel: +356-21 37 64 36 |
Deutschland UCB Pharma GmbH Tel: +49-(0)2173 48 48 48 | Nederland UCB Pharma B.V. Tel: +31-(0)76-573 11 40 |
Eesti UCB Pharma Oy Finland Tel: +358-92 514 4221 (Soome) | Norge UCB Nordic A/S Tlf: +45-32 46 24 00 |
Ελλ?δα UCB Α.Ε. Τηλ: +30-2109974000 | Österreich UCB Pharma GmbH Tel: + 43-(0)1 291 80 00 |
España UCB Pharma S.A. Tel: +34-91 570 34 44 | Polska UCB Pharma Sp. z o.o. Tel.: +48-22 696 99 20 |
France UCB Pharma S.A. Tél: +33-(0)1 47 29 44 35 | Portugal BIAL-Portela & Cª, S.A. Tel: +351-22 986 61 00 |
Hrvatska Medis Adria d.o.o. Tel: +385-(0)1 230 34 46 | România UCB Pharma România S.R.L. Tel: +40-21 300 29 04 |
Ireland UCB (Pharma) Ireland Ltd. Tel: +353-(0)1-46 37 395 | Slovenija Medis, d.o.o. Tel: +386-1 589 69 00 |
Ísland Vistor hf. Sími: +354-535 7000 | Slovenská republika UCB s.r.o., organizačná zložka Tel: +421-(0)2 5920 2020 |
Italia UCB Pharma S.p.A. Tel: +39-02 300 791 | Suomi/Finland UCB Pharma Oy Finland Puh/Tel: +358-92 514 4221 |
Κ?προς Lifepharma (Z.A.M.) Ltd Τηλ: +357-22 05 63 00 | Suomi/Finland UCB Pharma Oy Finland Puh/Tel: +358-92 514 4221 |
Latvija UCB Pharma Oy Finland Tel: +358-92 514 4221 (Somija) |
Date of Last Revision of this Package Insert:
Other Sources of Information
Detailed information about this medicine is available on the European Medicines Agency website https://www.ema.europa.eu
The average price of NEUPRO 3 mg/24h TRANSDERMAL PATCH in October, 2025 is around 48.71 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.